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                                            Abstract 
 
 
 
 This study was done to isolate corynebaterium pseudotuberculosis the 
causative agent of caseaus lymphadenitis in sheep and to determine the 
quality and quantity of short chain fatty acids among the isolates to study  
the possible association between fatty acids with pathogenicity in mice. 
 In Al-Huda slaughterhouse at Omdurman Province 3875 sheep 
carcasses were examined  for the presence of abscesses. By manual 
palpation only 67 (1.37%) head of sheep were found to have frank 
enlargement in the superficial lymph nodes. At post-mortem examination 
129 (3.32%) carcasses were found to have one to  three abscesses each.  
          A total of 157 lesions were collected and examined bacteriologically. 
C. pseudotuberculosis was isolated and identified to the species level from 
49 sample. Anti-beta haemolysin inhibition test was done and all strains 
tested were positive. Qualitative and quantitative analysis for short chain 
fatty acids among 20 isolates was done by using Gas liquid chromatography. 
Propionic acid was found in all isolates and formed the highest peak, but 
Valaric acid was not found. The differences in percentage composition of 
fatty acids has considerable taxonomic value to differentiate the isolates. 
Molecular characterization for 5 isolates of C. pseudotuberculosis by  PCR 
was attempted using primer targeting the 16r RNA gene. 
           These five strains were used to study the pathogenicity in mice and 
we found that the most pathogenic strains had  high concentration of 
Propionic acid while the non pathogenic strain has low concentration . 
           In view of that, we put forward, the fact that the content of this fatty 
acid might contribute with other factors in virulence.   
iiv 
  
  
  ﻤﻠﺨﺹ ﺍﻻﻁﺭﻭﺤﺔ
  
ﺴﺒﺒﻪ ﻟﻤﺭﺽ ﺍﻟـﺴل ﺍﻟﻜـﺎﺫﺏ ﻓـﻲ ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻌﺯل ﺍﻟﺒﻜﺘﺭﻴﺎ ﺍﻟﻌﺼﻭﻴﺔ ﺍﻟﻭﺘﺩﻴﺔ ﺍﻟﻤ    
  . ﺍﻟﺩﻫﻨﻴﺔ ﻗﺼﻴﺭﺓ ﺍﻟﺴﻠﺴﻠﺔ ﻓﻲ ﺍﻟﺒﻜﺘﻴﺭﻴﺎ ﺍﻟﻤﻌﺯﻭﻟﺔﺍﻟﻀﺄﻥ ﻭﻗﻴﺎﺱ ﻜﻤﻴﺔ ﻭ ﻨﻭﻋﻴﺔ ﺍﻻﺤﻤﺎﺽ
 ﻤﻥ ﺍﻟﻀﺄﻥ ﻋـﻥ  ﺭﺃﺱ5783ﺘﻡ ﺘﻔﺘﻴﺵ ﺘﻡ ﺠﻤﻊ ﺍﻟﻌﻴﻨﺎﺕ ﻤﻥ ﺴﻠﺨﺎﻨﺔ ﺍﻟﻬﺩﻯ ﺒﺄﻤﺩﺭﻤﺎﻥ ﺤﻴﺙ   
ﺃﻤـﺎ %( 37.1 )76ﻴﻤﻔﺎﻭﻴﺔ ﺍﻟﺨﺎﺭﺠﻴﻪ ﻭﻭﺠﺩ ﺃﻥ ﻋﺩﺩ ﺍﻟﺤﻴﻭﺍﻨﺎﺕ ﺍﻟﻤـﺼﺎﺒﻪ ﻠﻟﻐﺩﺩ ﺍﻟﻁﺭﻴﻕ ﺠﺱ ﺍ 
 921ﻭﺠـﺩ ﺍﻥ ﻋـﺩﺩ ﺍﻟﺤﻴﻭﺍﻨـﺎﺕ ﺍﻟﻤـﺼﺎﺒﻪ ﻋﻨﺩ ﻓﺤﺹ ﺍﻟﻀﺄﻥ ﺍﻟﻤـﺫﺒﻭﺡ ﻓـﻲ ﺍﻟـﺴﻠﺨﺎﻨﻪ 
 ﺤﻴﺙ ﺘﻡ ﺘﺴﺠﻴل ﻋﺩﺩ ﻭ ﺘﻭﺯﻴﻊ ﺍﻟﺨﺭﺍﺠﺎﺕ ﻓﻲ 3 ﺍﻟﻲ 1ﻭﻴﺘﺭﺍﻭﺡ ﻋﺩﺩ ﺍﻟﺨﺭﺍﺠﺎﺕ ﻤﻥ %(23.3)
ﺘﺭﻴـﺎ ﺍﻟﻌـﻀﻭﻴﺔ ﺎ ﻤﻌﻤﻠﻴﺎﹰ ﻓﻴﻡ ﺘﻡ ﻋﺯل ﺍﻟﺒﻜ  ﻏﺩﺓ ﻟﻴﻤﻔﺎﻭﻴﺔ ﺜﻡ ﺘﻡ ﻓﺤﺼﻬ 751 ﺘﻡ ﺠﻤﻊ .ﻜل ﺯﺒﻴﺢ 
ﺩﻡ ﺍﻟﺤﻤﺭﺍﺀ ﻭﻗـﺩ ﻜﺎﻨـﺕ ﻜـل ﺘﻡ ﺍﺠﺭﺍﺀ ﺍﺨﺘﺒﺎﺭ ﺘﺜﺒﻴﻁ ﺘﻜﺴﻴﺭ ﻜﺭﻴﺎﺕ ﺍﻟ .  ﻋﻴﻨﺔ 94ﺍﻟﻭﺘﺩﻴﺔ ﻤﻥ 
  .ﺍﻟﻌﻴﻨﺎﺕ ﻤﻭﺠﺒﺔ
 ﻋﺘـﺭﺓ ﺒﺎﺴـﺘﺨﺩﺍﻡ  02ﺘﻡ ﻗﻴﺎﺱ ﺍﻟﻨﺴﺒﺔ ﺍﻟﻤﺌﻭﻴﺔ ﻟﻼﺤﻤﺎﺽ ﺍﻟﺩﻫﻨﻴﺔ ﻗﺼﻴﺭﺓ ﺍﻟﺴﻠـﺴﻠﺔ ﻟﻌـﺩﺩ   
ﻑ ﻓﻲ ﻜﻤﻴﺔ ﻭﻨﻭﻋﻴﺔ ﺍﻻﺤﻤﺎﺽ ﺍﻟﺩﻫﻨﻴﺔ  ﻭﻭﺠﺩ ﺍﻥ ﻫﻨﺎﻙ ﺍﺨﺘﻼ ﺠﻬﺎﺯﺍﻟﻔﺼل ﺍﻟﻠﻭﻨﻲ ﺍﻟﻐﺎﺯﻱ ﺍﻟﺴﺎﺌل 
 ﻭﺠﺩ ﺍﻥ ﺤﻤﺽ ﺍﻟﺒﺭﻭﺒﻴﻭﻨﻴﻙ ﻤﻭﺠـﻭﺩ .ﺘﻡ  ﺘﻘﺴﻴﻡ ﻫﺫﻩ ﺍﻟﻌﺘﺭﺍﺕ ﻟﻤﺠﻤﻭﻋﺎﺕ  ﺤﻴﺙﻗﺼﻴﺭﺓ ﺍﻟﺴﻠﺴﻠﺔ 
  . ﻓﻲ ﻜل ﺍﻟﻌﻴﻨﺎﺕ ﺒﺄﻋﻠﻲ ﺘﺭﻜﻴﺯﺒﻴﻨﻤﺎ ﻟﻡ ﻴﻭﺠﺩ ﺤﻤﺽ ﺍﻟﻔﺎﻟﺭﻴﻙ
 ﺘﻡ ﺍﻟﺘﻌﺭﻑ ﻋﻠﻲ ﺨﻤﺴﺔ ﻋﺘﺭﺍﺕ ﺍﺴـﺘﻌﻤﻠﺕ ﻓـﻲ ﺘﺠﺭﺒـﺔ ﺘﻔﺎﻋل ﺍﻟﺒﻠﻤﺭﻩ ﺍﻟﻤﺘﺴﻠﺴل ﺒﻭﺍﺴﻁﺔ    
ﻭﺠـﺩ ﺃﻥ ﺍﻟﻌﺘـﺭﺍﺕ ﺫﺍﺕ ﺍﻟﺘﺭﻜﻴـﺯ ﺍﻟﻌـﺎﻟﻲ ﻟﺤﻤـﺽ .ﺔ ﻓﻲ ﺍﻟﻔﺌﺭﺍﻥ ﺍﻟﺒﻴﻀﺎﺀ ﺍﺤﺩﺍﺙ ﺍﻻﻤﺭﺍﻀﻴ 
  .ﻤﻥ ﻏﻴﺭﻫﺎ ﺫﺍﺕ ﺍﻟﺘﺭﻜﻴﺯ ﺍﻟﻤﻨﺨﻔﺽ ﻟﻨﻔﺱ ﺍﻟﺤﻤﺽﺍﻟﺒﺭﺒﻴﻭﻨﻴﻙ ﻜﺎﻨﺕ ﺃﻜﺜﺭ ﺍﻤﺭﺍﻀﻴﺔ 
 ﻨﺨﻠﺹ ﻤﻥ ﻫﺫﺓ ﺍﻟﺩﺭﺍﺴﻪ ﺍﻥ ﻗﻴﺎﺱ ﺍﻻﺤﻤﺎﺽ ﺍﻟﺩﻫﻨﻴﺔ ﻗﺼﻴﺭﺓ ﺍﻟﺴﻠﺴﻠﺔ ﻴﺴﺎﻫﻡ  ﻓـﻲ ﺘﻘـﺴﻴﻡ    
ﺒﻌﺽ ﺍﻟﻌﻭﺍﻤل ﺍﻻﺨـﺭﻱ ﻓـﻲ ﺘﺤﺩﻴـﺩ ﺭﺜﻭﻤﺔ ﺍﻟﻌﺼﻭﻴﺔ ﺍﻟﻭﺘﺩﻴﻪ ﺍﻟﻲ ﻋﺘﺭﺍﺕ ﻭﻗﺩ ﻴﺴﺎﻫﻡ ﻤﻊ ﺍﻟﺠ
 .ﺍﻤﺭﺍﻀﻴﺔ ﻭ ﻀﺭﺍﻭﺓ ﺍﻟﻌﺘﺭﻩ
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                                                               Introduction  
 
  
    According to official estimation, Sudan in 1994-95 had 103 million heads 
of livestock, sheep, cattle, goats and camels comprise the major meat-
producing animals. Live animals are continuously in demand from the Arab 
countries because of their healthy attractive appearance, clean skin, and 
conformity to international specifications. The vast natural pastures scattered 
all over the Sudan provide meat free of chemicals and hormones. However, 
this important trade has been threatened by the occurrence of caseous 
lymphadenitis (CLA) among exported sheep. Ships are continuously 
returned from ports of entry in importing  countries due to the disease.  
 Thus inflicting heavy financial losses on sheep exporters and national 
economy. In Sudan, in spite of massive economic losses, no control 
measures are available at present. Antibiotic treatment is ineffective because 
viable C. pseudotuberculosis remains protected by the capsule bounding the 
abscess. 
 This had led recently to an excitement and an upsurge in the study of 
the aetiology of caseous lymphadenitis with the aim to control the disease by 
vaccination or strict control measures. The main objectives of the present 
study were as follows:- 
1. To isolate C. pseudotuberculosis and study the bacteriological 
characterization of the organism. 
2. To determine the percentage composition of short fatty acid of the 
isolates by using gas liquid chromatography. 
3. To confirm the identification of isolates by PCR.  
 ix
4.  To study the possible association between short chain fatty acids with 
pathogenicity in mice. 
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Chapter one 
Review of Literature 
 
 
 
 
1.1. History: 
In 1888, the French bacteriologist Edward Nocard isolated an 
unusual organism from a case of lymphangitis in a cow (Nocard, 1896). 
Some 3 years later, the Bulgarian bacteriologist Hugo von Preïsz 
identified a similar bacterium in cultures from a renal abscess in a ewe 
(Preïsz and Guinard, 1891). As a consequence of these related 
discoveries, the organism in question became known as the “Preïsz–
Nocard” bacillus, a vernacular name with which it was linked for decades 
thereafter.  
Towards the end of the 19th century the bacterium was described 
by the German bacteriologists Lehmann and Neumann in the first edition 
of their bacteriological atlas (Lehmann and Neumann, 1896). In that 
publication, the Preïsz–Nocard bacillus was renamed Bacillus 
pseudotuberculosis—a derivation of the Greek pseudes tuberculosis or 
“false tuberculosis” and a reference to the supposed clinical similarity of 
the lesions to caseous nodules of mycobacterial tuberculosis. In the First 
Edition of Bergey's Manual of Determinative Bacteriology, published in 
1923, the organism was placed in the Corynebacterium genus, which had 
originally been created as a category for the human pathogen 
Corynebacterium diphtheriae. This edition of the Manual referred to 
work showing that B. pseudotuberculosis resembled C. diphtheriae in 
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morphology and cell wall composition, leading to a further change of 
name to Corynebacterium ovis. Subsequently, however, the organism was 
isolated from purulent infections and ulcerative lymphangitis in other 
mammalian species, including goats, horses and human beings. In 
recognition of this, by the time the Sixth Edition of Bergey's Manual was 
published in 1948, the species name had been changed back from ovis to 
the earlier designation of pseudotuberculosis. Since that point, the 
officially recognized designation of Corynebacterium pseudotuberculosis 
has remained consistent, notwithstanding the fact that several authors 
continued to refer to the organism as C. ovis until the 1980s.  
1.2. Geographical Distribution: 
The global range of C. pseudotuberculosis reflects that of farmed 
small ruminants, the bacterium having been identified in Europe, 
Australasia, North and South America, Africa and the Middle East 
(Robins, 1991; Paton et al., 2005). In many of these countries CLA has 
been an established and economically important infection of livestock, 
particularly sheep, for decades. As early as the 1930s it was 
acknowledged that the disease “very extensively affected” the flocks of 
most mutton-exporting countries (Cesari, 1930).  
Some suggestions have been made that the origins of the infection 
may lie in Europe, and that spread of C. pseudotuberculosis around the 
world followed the exportation of sheep by the 18th-century colonial 
powers. The Merino breed, which originated in Spain, was widely valued 
as a dual meat and wool animal and was exported extensively, first to 
South Africa and subsequently to Australia and the Americas. It has been 
suggested that this early exportation may, at the very least, have assisted 
in the spread of C. pseudotuberculosis (Paton, 2000). Such a theory is 
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difficult to prove, but supporting evidence might be provided by 
demonstration of a close genotypic relationship between isolates from 
different parts of the world. 
   Research interest in CLA was renewed in the 1970s, when the 
authorities in the USA, Canada and Japan applied strict regulations 
relating to the presence of lesions in imported sheep carcases. A further 
series of studies into disease pathogenesis and epidemiology was then 
initiated in Australia, which, as a major exporter of sheep and a high CLA 
prevalence within its national flock, had much to lose from the stricter 
regulatory regime. This in turn led to the formulation of control strategies 
aimed at reducing disease prevalence and provided a catalyst for 
developments in the field of vaccination. 
1.2.1.Caseous lymphadenitis in Sudan: 
           In Sudan the disease in sheep was first reported in the year 1914 
from sennar .Since that time the disease was associated with economic 
losses in a variety of ways which include meat condemnation and 
downgrading of hides. Lab our cost and antibiotics used to combating the 
disease are additional factors of economical loss.    
1.3. Bacterial Characteristics: 
1.3.1. Classification: 
The Corynebacteriaceae are now considered to belong to the 
Actinomycetaceae, a family that also contains the Mycobacterium, 
Rhodococcus and Nocardia genera (Clarridge and Spiegel, 1995). C. 
pseudotuberculosis possesses many of the classical features of its genus 
(Collins and Cummins, 1986). It consists of non-motile pleomorphic rods 
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(0.5–0.6 µm by 1.0–3.0 µm) that are Gram-positive, although such 
staining may sometimes be irregular. Groups of the bacteria tend to show 
a characteristic palisade or “Chinese letter” arrangement in smears.  
At a temperature of 37 °C, C. pseudotuberculosis will grow under 
aerobic or anaerobic conditions. On solid media, the bacterial colonies are 
pale in colour, dry and friable in consistency, and may be moved freely 
over the surface of the agar with the point of a probe (Quinn et al., 1994). 
After incubation for 24 h, small yellowish colonies will appear, 
increasing to a diameter of 1–2 mm after 48 h (Coyle et al., 1985). 
Bacterial growth benefits from the addition of serum or whole blood to 
nutrient media. When whole blood is used, a narrow band of β-
haemolysis is seen around each colony, although it may appear only after 
incubation for 48–72 h.  
When grown in liquid media or when in aqueous suspension, C. 
pseudotuberculosis has a tendency to form clumps. This has been related 
to the presence of long-chain 2-branched 3-hydroxy fatty acids (so-called 
“mycolic acids”), on the outside of the cell wall (Carne et al., 1956). 
Mycolic acids were first identified in 1939, in the tubercle bacillus 
(Asselineau and Lanéelle, 1998) and were subsequently found to be a 
feature common to the actinomycete family as a whole. Mycolic acids 
may be solvent-extracted from C. pseudotuberculosis without impairing 
the viability of the organism (Carne et al., 1956).  
The so-called “chemotaxonomic” approach to the classification of 
bacteria, based on analysis of the chemical composition of the cell wall, 
was at one time used relatively commonly. Analysis of cell wall mycolic 
acids greatly aided clarification of the taxonomy of actinomycetes, 
especially those of the genera Corynebacterium, Mycobacterium, 
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Rhodococcus and Nocardia (Minnikin et al., 1975; Goodfellow et al., 
1976; Keddie and Cure, 1977; Minnikin and Goodfellow, 1980; Collins et 
al., 1982). In these studies, thin-layer (pyrolysis) chromatographic 
analysis of mycolic acid revealed that fatty acid chain length varied 
according to the genus and to a lesser extent the species. It was shown 
that mycobacterial mycolic acids normally consist of chain lengths of 
between 60 and 90 C14 atoms, and may possess a number of distinct 
functional groups (Minnikin et al., 1978). In contrast, nocardiae and 
rhodococci were shown to possess shorter mycolic acids, consisting of 
between 36 and 66 C14 atoms, and with fewer functional groups 
(Minnikin and Goodfellow, 1976). The mycolic acids of corynebacteria 
were found to be even smaller, being between 20 and 36 C14 atoms in 
length, and usually saturated or containing a single double bond 
(Minnikin et al., 1978). Collins et al. (1982) reported that, consistent with 
the mycolic acid classification of corynebacteria, strains of C. 
pseudotuberculosis possessed mycolic acids with carbon chain lengths of 
between C26 and C36, which contained predominantly saturated C14 side-
chains (Collins et al., 1982).  
There are few published data on the resistance of C. 
pseudotuberculosis to chemical disinfectants. However, most common 
disinfectants, including calcium hypochlorite, formalin and cresol 
solution, appear to be effective in killing the organism, but the presence 
of organic material necessitates increased exposure time (Ismail and 
Hamid, 1972). This protective effect is clearly significant for a pathogen 
commonly found within a thick matrix of purulent debris. The organism 
is capable of surviving in commercial sheep dip solutions for 24 h or 
more, a point of relevance to disease control (Nairn and Robertson, 
1974).  
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Early reports showed that C. pseudotuberculosis isolates from 
different mammalian species shared identical biochemical characteristics, 
with the exception of nitrate reduction. Thus, the majority of isolates 
from horses and cattle reduced nitrate to nitrite, while those from sheep 
and goats did not (Knight, 1969; Sutherland et al., 1996). This led to the 
proposal of two distinct biotypes or subspecies (Biberstein et al., 1971). 
Based on this property of nitrate reduction, Songer et al. (1988) proposed 
the designations C. pseudotuberculosis biovar ovis (biotype 1) and C. 
pseudotuberculosis biovar equi (biotype 2). However, the isolation in 
recent years of nitrate-negative strains of C. pseudotuberculosis from 
cattle (Yeruham et al., 1997) and from horses (Connor et al., 2000) 
suggests that such categorization may be unsatisfactory.  
A further minor difference between certain isolates lies in the area 
of antibiotic sensitivity. In a comparison of susceptibility to 17 different 
antimicrobial agents, the minimum inhibitory concentration of amikacin 
was higher for nitrate-negative sheep and goat isolates than for nitrate-
positive equine and bovine isolates (Costa et al., 1998); however, the 
significance of this finding is not clear.  
1.3.2. Virulence Factors: 
No avirulent strain of C. pseudotuberculosis has yet been described; 
however, the organisms virulence mechanisms remain poorly understood. 
Since no plasmids have been identified in isolates of C. 
pseudotuberculosis, the absence of plasmid-encoded virulence 
determinants must be assumed. To date, research has focussed mainly on 
two known virulence factors identified as phospholipase D and mycolic 
acids. The genome of C. pseudotuberculosis, unlike that of a number of 
other bacterial pathogens, has yet to be fully sequenced; as a result, there 
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is at present no opportunity to identify novel gene sequences that may 
encode other virulence factors.  
1.3.2.1. Phospholipase D.: 
PLD in this organism was first characterized by Carne (1940) and has 
since been detected in every isolate of C. pseudotuberculosis that has 
been studied, including isolates of both of the suggested biotypes, and all 
known strains of the organism recovered from infected mammalian 
species (Songer et al., 1988). The contention that PLD represents a 
significant virulence factor is supported by much experimental evidence. 
Isolates of C. pseudotuberculosis in which the pld gene, encoding PLD, 
has been deleted from the chromosome or rendered inactive by mutation 
are incapable of causing the classic lymph node abscesses of CLA in 
sheep (Hodgson et al., 1992; McNamara et al., 1994). Similarly, the 
presence of specific antibody to PLD greatly limits the progress of the 
clinical disease.  
PLD is defined as a sphingomyelin-specific phospholipase that 
catalyses the dissociation of sphingomyelin into ceramide phosphate and 
choline (Bernheimer et al., 1980; Pepin et al., 1994a). The C. 
pseudotuberculosis pld gene has been cloned and sequenced. Analysis 
reveals that it encodes a protein of some 31.4 kDa, preceded by a 
probable secretory signal sequence of 2.7 kDa (Hodgson et al., 1990). 
The relatively large size of the protein molecule assists in its purification 
in the laboratory and enables large quantities to be collected (Egen et al., 
1989). Several biological activities have been reported for PLD, including 
dermonecrosis (Carne, 1940; Muckle and Gyles, 1986), lethality 
(Brogden and Engen, 1990), synergistic lysis of erythrocytes in the 
presence of an extracellular Rhodococcus equi factor (Fraser, 1961), and 
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inhibition of staphylococcal lysin-induced lysis of erythrocytes (Zaki, 
1976); the two latter activities are employed as laboratory tests for the 
identification of C. pseudotuberculosis. PLD also interferes with ovine 
neutrophil chemotaxis and is lethal to the cells themselves (Yozwiak and 
Songer, 1993). In terms of the significance of PLD as a virulence factor, 
the activity that has been the focus of most interest is the increase in 
vascular endothelial membrane permeability engendered by the 
hydrolysis of sphingomyelin. This increased permeability leads to the 
leakage of plasma from blood vessels and into the surrounding tissues, 
and from there into the lymphatic drainage (Jolly, 1965; Carne and Onon, 
1978). This effect may assist pathogenesis by favouring the lymphatic 
drainage of C. pseudotuberculosis in tissue fluid (Batey, 1986c).  
PLD may assist the organism at the site of initial infection in other 
ways. It is known to activate the complementary pathway of the innate 
immune system, thereby depleting complement in the region surrounding 
the invading bacteria and protecting them from opsonization (Yozwiak 
and Songer, 1993). It may also impair the chemotaxis of neutrophils and, 
as a consequence, decrease the likelihood of phagocytosis early in 
infection (Yozwiak and Songer, 1993). In some respects this suggestion is 
at odds with other theories of pathogenesis, which propose that in the 
early stages of disease the organism parasitizes phagocytic cells and 
multiplies within them. Indeed, other authors have indicated that PLD 
may play a role in the escape of the bacterium from within macrophages. 
It is possible that this role is related to the action of PLD on the inner 
phospholipid layers of the macrophage cell membrane, as indicated by 
comparable observations on other bacterial infections (Titball, 1993). 
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1.3.2.2. Exotoxins: 
Exotoxins with similarities to the PLD of C. pseudotuberculosis 
are known to be important virulence factors for other bacterial pathogens. 
For example, there is 97% homology between C. pseudotuberculosis 
PLD and the active exotoxin of C. ulcerans, a rare cause of human 
diphtheria (McNamara et al., 1995). A PLD-like exotoxin is also 
considered to be an important virulence factor in Pseudomonas 
aeruginosa (Wilderman et al., 2001). Likewise, pld shows homology to 
the ymt gene from the plague-causing organism Yersinia pestis 
(Hinnebusch et al., 2000). PLD also demonstrates an intriguing similarity 
in structure and biological activity to an enzyme toxin produced by the 
venomous North American brown recluse spider, Loxosceles reclusa 
(Bernheimer et al., 1985). This toxin induces dermonecrosis, haemolysis, 
platelet-aggregation and, on rare occasions, fatal renal failure (Lee and 
Lynch, 2005). Similarly, Hsu et al. (1985) showed that severe haemolytic 
crises resulted from the injection of C. pseudotuberculosis culture 
supernates or crudely purified exotoxin preparations into small ruminants.  
1.3.2.3. Mycolic acid: 
 Corynebacterium pseudotuberculosis does not produce a 
protective capsule but has instead a waxy mycolic acid coat on the cell 
wall surface (described above). This coat has well-established cytotoxic 
properties, which play a major role in pathogenicity (Hard, 1972; Muckle 
and Giles, 1983; Tashjian and Campbell, 1983). The subcutaneous 
injection into mice of mycolic acid extracted from C. pseudotuberculosis 
results in the production of a localized swelling, with congestion and a 
central area of haemorrhagic necrosis. In addition, mycolic acid induces 
degenerative changes and death in phagocytizing leucocytes (Carne et al., 
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1956). However, unlike the lethal effect of injection of similar molecules 
extracted from mycobacteria, the cytotoxic effect of C. 
pseudotuberculosis mycolic acid is confined to the site of injection (Hard, 
1975).  
Some authors have suggested that the mycolic acid coat enables C. 
pseudotuberculosis to survive for extended periods within the 
environment, a feature common to other members of the actinomycete 
family. C. pseudotuberculosis is indeed relatively resistant to 
environmental conditions (West et al., 2002). Low ambient temperatures 
and mixing with particulate fomites enhance survival of the organism in 
discharged pus, viable bacteria being recoverable from inanimate surfaces 
for up to 55 days after contamination (Augustine and Renshaw, 1986). 
Batey (1986c) reported that under cold and damp conditions, the 
organism may remain viable in a farm environment for 6 months or more. 
Soil experimentally contaminated with pus still contained viable bacteria 
8 months later (Brown and Olander, 1987). Thus, the environment may 
remain infectious for a significant period after contamination by an 
affected sheep.  
In natural infections, the waxy mycolic acid coat of C. 
pseudotuberculosis provides the organism with mechanical, and possibly 
biochemical, protection from the hydrolytic enzymes present within 
lysosomes. This in turn enables the bacterium to survive phagocytosis 
and to exist within the host as a facultative intracellular parasite 
(Williamson, 2001). This capacity is likely to be essential for the 
migration of the organism from the point of initial entry to the eventual 
site of lesion development. In addition, the toxic nature of mycolic acid 
seems to contribute to abscess formation. In artificial infections of mice, a 
direct relationship was demonstrated between the quantity of cell wall 
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lipid produced by different isolates of C. pseudotuberculosis and their 
ability to produce chronic abscessation (Muckle and Gyles, 1983).  
1.3.2.4. Other virulence factors:  
A previously unreported 40 kDa protein antigen of C. 
pseudotuberculosis, suggested by Walker et al. (1994) to be a virulence 
factor, has yet to receive detailed study.  
1.3.2.5. Other secondary factors: 
 Undetermined differences in virulence factors have been suggested to 
account for the specific “ovine/caprine” and “equine/bovine” strains of C. 
pseudotuberculosis, which are in other respects (cultural, antigenic and 
toxigenic) equivalent (Valli and Parry, 1993). The fact that the equine 
disease syndromes associated with the organism appear to be absent from 
large parts of the world in which the ovine infection is endemic, supports 
the existence of such differences. As discussed later, the probable 
importance of secondary factors, such as insect vectors, in C. 
pseudotuberculosis infections of horses may go some way to explaining 
this. However, in order to clarify the matter experimental infections with 
ovine and equine strains in parallel would be required.  
1.4. Clinical and pathological features of caseous lymphadenitis in 
sheep: 
Corynebacterium pseudotuberculosis infections in sheep are 
classically associated with the formation of pyogranulomas (Valli and 
Parry, 1993), and this accounts for the name “caseous lymphadenitis”. 
The lesions occur in two main forms, namely external (also known as 
superficial or cutaneous) and visceral, which may co-exist within the 
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same animal. The external form is characterized by abscessation of those 
lymph nodes that may be palpated externally. Any of the superficial 
lymph nodes of the body may be affected, dependent upon the original 
point of entry of the organism. Less commonly, localized purulent lesions 
not directly associated with the superficial lymph nodes may occur within 
the subcutaneous tissues. Such lesions may appear as organized 
abscesses, with swelling, fibrous encapsulation, loss of overlying hair and 
eventual rupture, resulting in the discharge of pus (Radostits et al., 2000).  
The visceral form is associated with abscesses in the internal 
lymph nodes and other organs. In sheep, the principal location of these 
internal CLA lesions is the lung parenchyma and mediastinal lymph 
nodes. Lesions may also be found in the liver, kidneys or udder, and more 
rarely the heart, testis, scrotum, uterus, joints, brain or spinal cord (Valli 
and Parry, 1993).  
1.4.1. Pathogenesis in sheep: 
There is a general consensus among recent reviewers regarding the 
stages through which C. pseudotuberculosis infection progresses. After 
initial entry, the organism spreads rapidly to the local drainage lymph 
node. Here, multiple microscopic pyogranulomas develop, growing in 
size and coalescing to form larger abscesses. This is sometimes followed 
by a further extension of infection via the blood or the lymphatic system, 
leading to similar lesions in other organs. The nature of these slowly 
developing CLA lesions means that chronic, and frequently lifelong, 
disease is the rule rather than the exception. Viable bacteria may be 
recovered from abscesses several years after initial infection. 
Reactivation of disease may also occur, with the development of lesions 
at new sites after a considerable period of apparent quiescence.  
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Numerous routes of inoculation have been used to induce 
experimental CLA in sheep; intradermal, subcutaneous, intravenous, 
intratracheal, intravaginal, and intralymphatic inoculation have all proved 
successful in establishing disease (Nagy, 1976; Burrell, 1978a; Pepin et 
al., 1994b; Fontaine et al., 2006). In natural infections, however, the 
principal route of entry is believed to be through the skin (Batey, 1986c; 
Brown and Olander, 1987; Davis, 1990; Collett et al., 1994). This initial 
infection is facilitated by minor cutaneous wounds and abrasions, 
especially those caused by shearing (Paton et al., 1988). Wounds caused 
during castration or docking have also been suggested as an occasional 
route of entry, as has the umbilicus in neonatal animals (Valli and Parry, 
1993). Entry via the oral cavity has been postulated to account for the 
small number of head and neck lesions seen in sheep from the Antipodes 
and North America, and the many more such lesions in goats (Ashfaq and 
Campbell, 1979). In contrast, the more distal parts of the intestinal tract 
are not believed to provide a portal of entry for the organism, even in the 
presence of parasitic damage (Valli and Parry, 1993).  
A respiratory route of infection, postulated by Stoops et al. (1984), 
has been widely quoted in subsequent reviews. This theory was based on 
the observations that some naturally infected sheep show only pulmonary 
lesions, and that a small number of these lesions are located within the 
walls of airways. Moreover, Brown and Olander (1987) reported the 
production of disseminated pulmonary abscesses by injecting 
intratracheally a broth culture of C. pseudotuberculosis. However, other 
studies have indicated that such pulmonary lesions may develop as part of 
a systemic infection initiated elsewhere in the body. Thus, after the 
intravenous inoculation of lambs with C. pseudotuberculosis, the majority 
of internal lesions appeared in the lungs and associated thoracic lymph 
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nodes (Brogden et al., 1984). It has also been noted that in natural ovine 
CLA infections, the patterns of distribution of pulmonary lesions are 
consistent with haematogenous or lymphogenous spread rather than with 
aerogenous spread (Nairn and Robertson, 1974). It would therefore 
appear that entry of infection via the respiratory tract, although a 
theoretical risk, is of minor importance.  
The use of radioisotopically labelled inflammatory cells and 
scintigraphic imagery demonstrated that, within a few hours of 
subcutaneous inoculation with bacteria, huge numbers of neutrophils 
were recruited to the injection site, and by 24 h post-inoculation, these 
neutrophils began to appear in the local drainage lymph node (Pepin et 
al., 1992); the relative importance of neutrophils decreased from day 3, 
while the relative numbers of macrophages at the site of inoculation rose 
dramatically. As suggested above, the ability of C. pseudotuberculosis to 
survive phagocytosis by such cells and to exist as a facultatively 
intracellular parasite enables the organism to be carried within these cells 
via the lymphatic drainage to the local lymph node (Pepin et al., 1994a). 
Thus, phagocytic cells recruited to the area in response to infection 
become the means by which further colonization of the body is brought 
about.  
Once a lymph node has been colonized by C. pseudotuberculosis it 
undergoes a short period of generalized inflammation. PLD, the soluble 
exotoxin produced by C. pseudotuberculosis, is the probable initiator of 
this lymphadenitis. Pepin et al. (1991) reported that within 24 h of the 
subcutaneous inoculation of lambs a number of micro-abscesses occurred 
within the cortical region of the lymph node draining the site of 
inoculation. By day six post-inoculation, these micro-abscesses had 
become more numerous and began to expand and coalesce to form larger 
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purulent foci. The early pyogranulomas contained clumps of bacteria and 
cellular debris, with a relatively high proportion of eosinophils, giving the 
purulent core a slightly green hue. At the same time, and in parallel with 
the cellular events at the point of entry, the infiltration of neutrophils 
diminished and monocytes/macrophages became the predominant cell 
type within the lesion (Pepin et al., 1994b). A process during which the 
lesion is encapsulated followed shortly thereafter, leading to a diminution 
of the inflammatory reaction in the parenchyma of the node. Continued 
slow expansion of the lesion sometimes then occurred, depending on the 
location of the node and whether or not it ruptured to discharge its 
contents. Such enlargement progressed through a repeated cycle of 
necrosis and reformation of the outer capsule. In the early stages, the 
purulent contents of the abscess were soft and semi-fluid; however, as 
time progressed, the pus within the lesion took on a more plastic or solid 
form, in which scattered clumps of bacteria were sometimes noted. Small 
nodules of mineralization formed within the purulent material, causing it 
to become progressively paler in colour. These calcified foci tended to be 
laid down in concentric layers reminiscent of the cross-sectional view of 
an onion. This classic “onion ring” presentation is regarded as virtually 
pathognomonic for CLA .Superficial lymph node abscesses may expand 
to reach a diameter of as much as 15 cm, but 3–5 cm is a more common 
size (Valli and Parry, 1993).  
It is likely that the infected superficial lymph node acts as staging 
post for the further colonization of internal lymph nodes and viscera; 
however, at which stage in the course of the infection such colonization 
occurs is the subject of some speculation. It seems probable that purulent 
emboli detach from pyogranulomas within the affected nodes, pass into 
the efferent lymphatic flow and are then delivered into the bloodstream 
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(Radostits et al., 2000). However, once encapsulation of a lymph node 
abscess has taken place, the escape of such infectious emboli seems likely 
to occur infrequently, if at all. Consequently, it has been argued that in 
most cases any colonization of organs beyond the local drainage lymph 
node must occur relatively quickly after initial infection, and that 
phagocytic cells may once again be the vehicles (Pepin et al., 1994a).  
Other than the lymph nodes, the lung is the most frequent site of 
CLA lesions. As already noted, the generally random distribution of 
lesions within the parenchyma is consistent with haematogenous or 
lymphogenous spread, with seeded lesions developing from within the 
alveolar vasculature (Batey, 1986c). These pulmonary lesions most 
commonly take the form of encapsulated abscesses similar to those seen 
in the lymph nodes, but occasionally a more extensive bronchopneumonia 
is also recorded (Valli and Parry, 1993). The latter may lead to areas of 
pleuritis, resulting in the development of fibrinous or fibrous adhesions to 
the chest wall, pericardium or diaphragm (Renshaw et al., 1979; Stoops et 
al., 1984). In animals with pulmonary abscesses, CLA lesions are 
occasionally encountered in the associated mediastinal and bronchial 
lymph nodes, implying an additional step in the transit of the organism 
from the lung parenchyma. Abscesses within the mediastinal lymph 
nodes may become so large as to put pressure on the adjacent 
oesophagus, interfering with normal swallowing and rumination, and 
leading to chronic ill-thrift (Paton et al., 2005).  
Mastitis due to C. pseudotuberculosis is encountered occasionally 
in sheep and is most likely to represent an extension of infection from the 
adjacent supra-mammary lymph node. It may take the form of an acute 
suppurative mastitis, or appear as chronic encapsulated abscesses within 
the mammary gland. Lesions in other organs such as the liver, kidneys 
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and scrotum also tend to be encapsulated abscesses containing a thick 
caseous material, which may again take on a lamellated form in chronic 
cases (Valli and Parry, 1993). On rare occasions, the organism has also 
been isolated from the stomach contents and tissues of ovine fetuses, 
consistent with a role in abortion (Dennis and Bamford, 1966). 
1.5. Control and eradication of disease in sheep: 
1.5.1. Diagnosis: 
For the successful control of CLA, it is first necessary to identify 
infected animals, so that they can be prevented from coming into contact 
with uninfected animals. The diagnostic criterion for CLA is the culture 
and identification of C. pseudotuberculosis. It is usually possible to 
isolate the organism from lesions of all ages, although the number of 
viable bacteria present in chronic abscesses may be low and apparently 
sterile lesions are occasionally encountered. In sheep, the presence of 
abscesses in external lymph nodes is highly suggestive of the disease, 
particularly if several animals in a group are similarly affected. Other 
bacterial pathogens, such as Actinobacillus licheniformis, 
Arcanobacterium pyogenes, and in some countries Staphylococcus aureus 
subsp. anaerobius, are all capable of producing suppurative 
lymphadenopathy (Bek-Pederson, 1997; Pekelder, 2000); however, these 
other infections tend to be sporadic in nature and are rarely seen as a 
flock problem.  
In the past, identification of Corynebacterium spp. has proved 
difficult for several reasons. These reasons include  insufficient numbers 
of reference strains with which to compare isolates, inadequacies in the 
reference data obtained from characterized strains, and the relative lack of 
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appropriate criteria, (Hill et al., 1978). It has long been considered that C. 
diphtheriae, C. pseudotuberculosis and C. ulcerans are related, as they 
share a similar morphology and cell wall composition, and all produce a 
characteristic halo on Tinsdale medium, indicating the production of a 
cystinase enzyme (Barksdale, 1970). However, on the basis of DNA 
homology, there would seem to be less similarity between the three 
species than was at one time thought (Groman et al., 1984). Nonetheless, 
C. pseudotuberculosis and C. ulcerans can be made to produce diphtheria 
toxin by infecting them with toxin-associated phages from C. diphtheriae 
(Saxholm, 1951; Henriksen and Grelland, 1952; Maximescu, 1968).  
In the laboratory, C. pseudotuberculosis cultured from clinical 
samples may be identified from its enzymatic profile and its ability to 
utilize various carbohydrate sources. The task of biochemical profiling 
has been greatly simplified by the introduction of standardized and 
miniaturized proprietary test kits, an example of which is the Analytical 
Profile Index (API) identification system (bioMérieux [UK], Basingstoke, 
Hampshire, UK). The “API Coryne” kit (used for the identification of 
coryneform bacteria) comprises 21 individual test substrates for the 
determination of enzymatic activity or carbohydrate fermentation. After 
inoculation with the test organism and incubation for a defined period, the 
metabolic end-products of the enzymatic tests result in the development 
of specific colour changes, either spontaneously or following the addition 
of reagents. For substrate fermentation tests, pH change is also detected 
colorimetrically. Subsequently, a particular combination of positive and 
negative test results is used to compile a numerical profile (an Analytical 
Profile Index; API), which is then used to “interrogate” a proprietary 
software database.  
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In addition to substrate utilization, further laboratory-based tests 
are available to identify C. pseudotuberculosis. Some years ago, it was 
noted that when β-lysin-producing staphylococci were cultured on blood-
containing solid media in the presence of strains of Streptococcus 
agalactiae that produce a secreted ‘factor’, enhanced zones of haemolysis 
were observed. This led to the discovery of an S. agalactiae protein, 
designated CAMP-factor, which on its own was unable to cause 
erythrocyte lysis. The synergistic lysis phenomenon was designated the 
CAMP-reaction (Christie et al., 1944). Similarly, when C. 
pseudotuberculosis and Rhodococcus equi are cultured together on solid 
blood-containing media, colonies of both species in close proximity to 
each other cause significant zones of erythrocyte lysis (Fraser, 1961). A 
similar phenomenon was noted when C. pseudotuberculosis was cultured 
in the presence of δ-lysin-producing staphylococci (Lovell and Zaki, 
1966). The R. equi protein (so-called equi factor) involved in synergistic 
lysis was found to be a phospholipase C enzyme (Bernheimer et al., 
1980). Currently this assay, which may also be performed by 
supplementing blood-containing solid media with R. equi culture 
supernate (containing equi factor), is used in diagnostic laboratories for 
the identification of C. pseudotuberculosis. However, it should be noted 
that C. ulcerans also produces PLD, although significantly it is the only 
other corynebacterial species found to do so (Barksdale et al., 1981). 
Hence, PLD activity is a distinctive marker within the genus 
Corynebacterium. 
1.5.2. Treatment: 
In vitro, C. pseudotuberculosis is sensitive to a range of antibiotic 
chemicals. In standard laboratory-based tests, most commonly used 
antibiotic classes have been shown to prevent bacterial growth and 
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multiplication (Muckle and Gyles, 1982; Judson and Songer, 1991). 
However, in vivo, clinical CLA is generally refractory to antibiotic 
therapy, probably because of the thick encapsulation around the typical 
lesions, and the thick and caseous nature of the pus contained within 
(Williamson, 2001). The intracellular nature of the organism during parts 
of the disease cycle is also believed to confer some protection from 
certain commonly employed antibiotics. Surgical treatment of external 
lesions has been suggested as an alternative to culling in the case of 
particularly valuable animals (Davis, 1990). Whether the lesion is 
surgically removed, or simply lanced and flushed-out daily until healed, 
parenteral antibiotic treatment for 4–6 weeks has been recommended to 
reduce the likelihood of recurrence. This course of action is still seen as 
unreliable at best, since it relies upon the antibiotic to remove all 
infecting organisms from the treated lesions, and assumes that no internal 
lesions are present. As a result, reports on the use of such techniques are 
not encouraging (Gezon et al., 1991; Rizvi et al., 1997).  
Significantly, in a recent report claims were made of successful 
treatment of C. pseudotuberculosis-infected sheep with a combination of 
the antibiotics rifamycin and oxytetracycline (Senturk and Temizel, 
2006). Rifamycin is primarily used against Mycobacterium tuberculosis 
and Mycobacterium leprae infections, and has an established ability to 
kill susceptible intracellular bacteria. In small trial, 10 CLA-affected 
animals received twice-daily treatment with rifamycin for a period of 10 
days, in association with injections of a depot formulation of 
oxytetracycline at intervals of 3 days. This led to a decrease in the size of 
CLA lesions in the external lymph nodes of affected sheep, producing 
what was described as a clinical resolution of the lesions. However, no 
necropsies followed the intensive treatment regime and the report did not 
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indicate for how long the sheep remained disease-free. Further studies are 
required before treatment of CLA cases becomes a viable alternative to 
culling (Baird, 2006).  
1.5.3. Serology: 
Whilst isolation and identification of C. pseudotuberculosis 
remains the gold standard in diagnosis of CLA, this may not always be 
advantageous or possible. The puncture of CLA abscesses generally 
releases pus on to the animal's skin or into the environment, presenting a 
risk of transmission of infection to other animals. Furthermore, chronic 
external lesions that have ruptured frequently become fibrosed and may 
contain little pus and few viable organisms. Finally, animals suffering 
from the visceral form of disease may show no external lesions that can 
be sampled, but remain a potential source of infection to others. Much 
research interest has therefore focussed on serological tests that might 
identify CLA without recourse to bacteriology.  
Most serological diagnostic tests for CLA are based on the 
detection of a humoral response to PLD exotoxin. Such tests have been 
explored as a method for controlling the disease in sheep by identifying 
and removing infected carrier animals. The use of serological tests for the 
laboratory diagnosis of C. pseudotuberculosis infection dates from the 
early years of the 20th century. Originally, determination of infection 
status relied upon the invivo demonstration of antitoxins (Forgeot and 
Cesari, 1912; Nicolle et al., 1912; Watson, 1920; Mitchell and Walker, 
1944; Doty et al., 1964; Zaki, 1976). Experimental subjects (mice, rabbits 
or guinea-pigs) were given injections of serum from animals suspected of 
being infected with C. pseudotuberculosis; they were then given lethal 
doses of PLD toxin, prepared from C. pseudotuberculosis culture 
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supernates. A reduction in the rate of mortality of serum-treated animals, 
as compared with that of controls, was considered to indicate passive 
protection by serum antitoxin, and to be highly suggestive of C. 
pseudotuberculosis infection.  
In a development that was to facilitate invitro serological 
screening, it was found that inclusion of antitoxin-containing sera in the 
CAMP-inhibition test resulted in neutralization of the inhibitory effect 
that C. pseudotuberculosis exerted on staphylococcal β-lysin; this led to a 
new method designated the anti-haemolysin-inhibition (AHI) test for 
testing sera from animals suspected of having CLA. This test has been 
used for disease diagnosis in sheep, goats and horses, avoiding the use of 
experimental animals (Zaki, 1968; Knight, 1978; Burrell, 1980; Brown et 
al., 1986).  
Other tests used in the study of CLA include tube agglutination 
assays (Cameron et al., 1972; Husband and Watson, 1977), an indirect 
haemagglutination test (Shigidi, 1978) and a double immunodiffusion test 
(Burrell, 1980). However, the enzyme-linked immunosorbent assay 
(ELISA) for use in diagnosis has shown particular promise. Initially 
CLA-diagnostic ELISAs employed crude C. pseudotuberculosis cell wall 
preparations or supernate-derived exotoxin as antigen (Maki et al., 1985; 
Ellis et al., 1990; Sting et al., 1998). Test sensitivity was usually regarded 
as good, but specificity was relatively poor—possibly due to cross-
reactions with other proteins present in the antigen preparations. 
However, some ELISAs have been claimed to be sufficiently specific and 
sensitive for field diagnosis. One such ELISA was based on a PLD 
antigen derived by recombinant technology from E. coli containing a 
plasmid bearing the pld gene (Menzies et al., 1994), a test sensitivity of 
86.3% and specificity of 82.1% being reported. The assay coming closest 
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to the requirements of a diagnostic test was reported by workers in the 
Netherlands (Ter Laak et al., 1992) and was later refined to improve 
specificity and sensitivity (Dercksen et al., 2000). This is an indirect 
double antibody sandwich ELISA, based on PLD exotoxin purified from 
the supernate of C. pseudotuberculosis culture, polyclonal rabbit anti-
PLD serum being used as a capture antibody. The improved method is 
reported to have a specificity in sheep of 99±1%, and a sensitivity of 
79±5%.  
Other potential tests include a polymerase chain reaction (PCR) 
method (Cetinkaya et al., 2002) and a bovine interferon (IFN)-γ whole 
blood ELISA (Menzies et al., 2004). The latter was the first test in which 
assay of cellular immunity to C. pseudotuberculosis was used as a 
diagnostic tool. Over the course of 1 year, the IFN-γ test accurately 
detected goats experimentally infected with C. pseudotuberculosis with a 
reliability of 89.2%, and non-infected goats with a reliability of 97.1% 
Over the same period, a recombinant PLD ELISA detected the 
experimentally infected goats with a reliability of 81.0% and non-infected 
goats with a reliability of 97.0%. The PLD ELISA was, however, more 
predictive than the IFN-γ ELISA of the lesions subsequently observed at 
necropsy. A later study of INF-γ production in cultures of whole blood 
compared infected goats following stimulation with either secreted 
bacterial antigen or somatic antigen; IFN-γ production by blood cells was 
found to be significantly higher in response to the secreted antigen 
(Meyer et al., 2005).  
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1.5.4. Vaccination: 
1.5.4.1. Bacterin vaccines: 
 The earliest reported vaccination trials in sheep were conducted in the 
Patagonia region of Argentina, where a formalin-killed C. 
pseudotuberculosis vaccine reduced infection by up to 60% (Quevedo et 
al., 1957). Cameron et al. (1972) made one of the first attempts to 
demonstrate by experimental challenge the ovine immune response to 
vaccination, the vaccine consisting of formalin-killed, whole cells of C. 
pseudotuberculosis. The intravenous challenge doses investigated varied 
from 2×107 to 2×1010 colony-forming units. However, it was difficult to 
obtain satisfactory results, the higher doses producing acute death due to 
pulmonary oedema and the lower doses failing to cause lesions. 
Furthermore, vaccination produced increased titres of serum antibody that 
persisted for only 3–4 months. Nonetheless, it was concluded that 
vaccination could protect sheep against the lethal effects of sub-acute 
infection but not against formation of the lesions associated with chronic 
infection. It was considered that effective immunity might not depend 
solely on circulating antibody, but that cellular immune responses might 
play a role. It was also suggested that, if used, a whole cell vaccine 
should be administered shortly before shearing.  
More recently, in a study of several vaccines, immunization of 
sheep with a formalin-killed, virulent, UK-derived C. pseudotuberculosis 
isolate and aluminium hydroxide adjuvant resulted in statistically 
significant protection against homologous challenge; the vaccine had 
prevented the spread of infection beyond the site of inoculation (Fontaine 
et al., 2006).  
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There have been few investigations of the protective effect of C. 
pseudotuberculosis bacterins against disease in the field. Menzies et al. 
(1991) conducted a field trial of a killed whole-cell vaccine in a flock of 
sheep and herd of goats, both populations having shown a prevalence of 
CLA in adult animals ranging from 15% to 30% in the pre-trial period. 
During the trial, lambs and kids were vaccinated at 2.5–3.5 months of 
age, with two further doses administered at 1 month and 11 months after 
the initial vaccination. The animals were regularly monitored for 36 
months after the initial dose of vaccine. Serum antibody concentrations 
were significantly increased in vaccinated sheep and goats for the full 
term of the experiment. Furthermore, vaccination significantly decreased 
the incidence of CLA in the sheep, and there was a suggestion of a 
similar effect in the goats.  
In a later study, juvenile sheep and goats were vaccinated with a C. 
pseudotuberculosis bacterin formulated in light mineral oil containing 
muramyl dipeptide (Brogden et al., 1995); the results, however, were 
inconclusive.  
1.5.4.2. Toxoid vaccines: 
 Most subsequent studies on CLA vaccination focussed on the use of 
bacterins, or on vaccines made from components of whole cells. 
However, a report by Jolly (1965) showed that the administration of 
toxoid, followed by toxin, reduced the extent of experimental CLA in 
sheep. This followed the observation by Cameron (1964) that an 
undefined “protoplasmic toxin” of C. pseudotuberculosis played a role in 
the induction of protective immunity. It was later demonstrated that C. 
pseudotuberculosis exotoxin was in reality identical with this 
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protoplasmic toxin (Cameron and Smit, 1970), adding weight to the 
hypothesis that PLD could be used as a protective antigen.  
Purely managemental strategies having failed to prevent the spread 
of the disease, studies were conducted in Australia during the 1970s to 
develop a CLA vaccine, work that would eventually lead to the first 
commercial CLA vaccine (Eggleton et al., 1991a) . The ability of PLD to 
protect against CLA was reported by both Nairn et al. (1977) and Burrell 
(1978b).  
Between 1977 and 1978, the technology required for production of 
an effective toxoid vaccine was made available to the Commonwealth 
Serum Laboratories (CSL; Parkville, Victoria, Australia). For vaccine 
production, PLD was obtained from filtered and concentrated C. 
pseudotuberculosis culture supernates, which were subsequently toxoided 
with formalin (Burrell, 1983; Hodgson et al., 1999). A combined 
clostridial and corynebacterial vaccine, known as Glanvac™, was 
released in 1983 (Eggleton et al., 1991); it subsequently became available 
in Australia and several other countries. In one report, vaccination of 
goats with Glanvac™ resulted in statistically significant protection 
against subsequent experimental infection with C. pseudotuberculosis, as 
measured by a reduction in the number of lesions (Brown et al., 1986). In 
addition, the results of trials performed in the process of the commercial 
development of Glanvac™ indicated significant protection of sheep 
against CLA (Burrell, 1983;)and (Eggleton et al., 1991a), , however, 
found that PLD toxoid gave greater protection when not combined with 
clostridial components.  
The mechanism by which Glanvac™ confers immunity has been 
the topic of some debate. It has been suggested that protection against 
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CLA is both humoral and cell-mediated, but that PLD is neutralized by 
circulating antibody (Burrell, 1978a; Sutherland et al., 1992). In contrast, 
Hodgson et al. (1999) discussed the possibility that the small amount (ca 
1%) of PLD activity that remained after formalin treatment (Eggleton et 
al., 1991b) might be responsible for the protection conferred by 
Glanvac™. However, Eggleton et al. (1991b) had previously reported 
that a four-fold variation in the level of active toxin remaining in a toxoid 
vaccine “neither enhanced nor reduced the protective potency of the 
vaccines”. Others have reported that anti-exotoxin antibodies are not on 
their own sufficient to prevent infection in the absence of other (probably 
cell-mediated) immune defences (Irwin and Knight, 1975; Ellis et al., 
1990). Significantly, Cameron and Smit (1970) stated that “…it could be 
expected that crude exotoxin preparations could also contain other 
antigens. Therefore, unless an absolutely pure preparation of exotoxin can 
be produced, its immunizing activity can never be accurately assessed”. 
This statement was later reiterated by Burrell (1983), who confirmed that 
the culture supernates used to prepare Glanvac™ contained other C. 
pseudotuberculosis somatic antigens, which varied in amount from batch 
to batch. Moreover, Walker et al. (1994) intermittently identified 
antibodies against a novel C. pseudotuberculosis antigen in sera from 
sheep vaccinated with Glanvac™. It would therefore seem that the 
presence of other C. pseudotuberculosis proteins in toxoid vaccines 
prepared from culture supernates may well contribute to the protective 
capacity of the vaccine.  
1.5.4.3. Combined vaccines: 
 In reviewing CLA vaccine development, Burrell (1983) stated that, 
despite the capacity of cell-associated antigens and PLD (Burrell, 1978b) 
to give some protection, full protection required the presence of both. In 
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defence of this, it was revealed that an alhydrogel-adjuvanted vaccine 
composed of formalin-killed whole C. pseudotuberculosis cells, enriched 
with formalin-treated, PLD-rich culture supernate, protected completely 
against experimental C. pseudotuberculosis infection and outperformed 
vaccines consisting of cell-free toxoided culture supernates (Burrell, 
1983). In contrast, a report of work conducted during the development of 
Glanvac™ revealed that supplementation of cell-free toxoid vaccine with 
C. pseudotuberculosis cells made no difference to the observed protection 
(Eggleton et al., 1991b).  
A further commercially available CLA vaccine (Caseous D-T™; 
Colorado Serum Co., Denver, CO, USA) contains clostridial toxoids and 
a combination of C. pseudotuberculosis bacterin and toxoid. Piontkowski 
and Shivvers (1998) reported that this vaccine gave some protection to 
sheep against experimental infection, in that it reduced the incidence of 
external and internal CLA lesions.  
Fontaine et al. (2006) reported that vaccination of sheep with a C. 
pseudotuberculosis bacterin enriched with recombinant PLD resulted in 
complete freedom from infection 3 weeks after experimental homologous 
challenge. It had been reported previously (Simmons et al., 1998) that C. 
pseudotuberculosis (even a non-virulent mutant) was capable of 
persisting within granulomas in the draining lymph node, as a result of 
the inaccessibility of abscesses to the immunological factors required to 
clear the infection. Therefore it was suggested that vaccination had 
enabled clearance of the organism prior to establishment within the 
lymph node.    
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1.5.3.4. Live vaccines:  
Pepin et al. (1993) reported that sheep infected experimentally with C. 
pseudotuberculosis were protected against further challenge, despite 
being unable to clear the original infection. This observation indicates the 
possible value of an attenuated vaccine.  
Because PLD is an important virulence factor (Carne and Onon, 
1978), Hodgson et al. (1992) hypothesized that genetic inactivation of the 
pld gene might provide the basis for a live recombinant veterinary 
vaccine. A mutant derivative of pld was constructed in vitro, by cloning 
the gene into a suitable plasmid vector (pEP2), and disrupting it by 
insertion of an erythromycin-resistance cassette. Subsequently, the 
resulting recombinant plasmid (pBTB58) was introduced into C. 
pseudotuberculosis by electroporation, and recombination between 
homologous plasmid-borne and chromosomal sequences resulted in 
replacement of the wild-type gene by the mutant copy. To ensure the 
stability of the mutation, pBTB58 vector sequences were removed from 
mutant cells by transformation with the plasmid pEP3; because pEP3 
possesses the same origin of replication as that of pBTB58, plasmid 
segregation resulted in loss of pBTB58 sequences and retention of pEP3.  
Inoculation of sheep with up to 107 colony-forming units of the 
PLD-deficient C. pseudotuberculosis strain (so-called “Toxminus”) failed 
to produce the abscessation normally associated with wild-type C. 
pseudotuberculosis. However, at higher doses, transient abscesses were 
formed at the inoculation site. Despite this, the authors concluded that the 
degree of attenuation was equivalent to at least a 100-fold reduction in 
infective dose. The vaccine potential of the attenuated strain was 
determined by challenge of Toxminus-immunized sheep with wild-type 
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C. pseudotuberculosis. A degree of protection against challenge and 
strong humoral and cellular immune responses were observed, but these 
effects were lower than those produced by wild-type infection.  
It was later postulated (Hodgson et al., 1994) that the rationale 
behind the creation of the Toxminus mutant was flawed: while the 
recombinant strain was attenuated for virulence and hence useful as a live 
vaccine vector, one of the major immunodominant antigens (PLD) had 
been removed, thus reducing immune stimulation. Hodgson et al. (1994) 
therefore constructed a mutant derivative of PLD in which the histidine20 
amino-acid residue (a constituent of the enzyme's active site) was 
substituted for tyrosine, and expression of the resulting plasmid-borne, 
mutant pld gene produced a biologically inactive derivative of PLD. On 
transformation of Toxminus with the inactivated pld construct, cells were 
able to secrete an inactive PLD derivative, albeit at a level lower than that 
of wild-type PLD.  
In an attempt to avoid inoculation-site reactions and to provide a 
convenient means of vaccine administration, Hodgson et al. (1994) 
administered each of two vaccines (Toxminus and Toxminus carrying the 
inactivated pld) to sheep via the oral route. Both vaccines induced 
significant and similar humoral immune responses. Furthermore, in 
animals immunized with the strain expressing the inactivated pld, 
challenge elicited a rapid anamnestic response to PLD; this response was 
quicker and of greater magnitude than the humoral response (1) to 
infection in unvaccinated animals, or (2) in those receiving Toxminus 
alone. Despite significant humoral responses, the protection against 
challenge conferred by the Toxminus strain was negligible; this 
contrasted with a previous report of subcutaneous vaccination with 
Toxminus (Hodgson et al., 1992). The difference in protection was 
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attributed to the failure of oral vaccination, unlike subcutaneous 
vaccination, to stimulate a significant Th1 immune response, IgG1 having 
been identified as the dominant IgG isotype. Despite the failure of 
Toxminus alone, immunization with Toxminus expressing the mutant pld 
gene resulted in significant protection against challenge, confirming the 
earlier observations that antibodies against PLD protected against CLA 
(Jolly, 1965; Nairn et al., 1977; Eggleton et al.,1991c) .  
Continued efforts to produce an effective live vaccine vector led to 
attempts to express a range of foreign antigens in the Toxminus strain, 
under the control of several different promoters (Moore et al., 1999). In 
the course of this work, Toxminus-based systems were developed to 
enable antigens to be expressed, intracellularly or in secreted form, as 
native or fusion proteins, either constitutively or by controlled induction. 
Furthermore, genes were successfully expressed from plasmids, or 
following integration into the Toxminus chromosome. In addition to 
derivatives of C. pseudotuberculosis pld, genes from other pathogenic 
organisms, including Mycobacterium leprae, Taenia ovis, Babesia bovis, 
Dichelobacter nodosus and Anaplasma marginale, were successfully 
expressed. Subsequently, it was revealed that subcutaneous immunization 
of sheep with Toxminus expressing inactive pld, or A. marginale or D. 
nodosus antigens, resulted in the induction of a significant humoral 
immune response; the same was not true, however, for T. ovis or B. bovis 
antigens. 
1.5.4.5. DNA vaccines: 
With the advent of DNA vaccination technologies, there have been 
reports of the successful immunization of numerous species against 
various micro-organisms (Donnelly et al., 1995), but such reports in 
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respect of farm livestock have been relatively few in number (Van 
Drunen Littel-van den Hurk et al., 2000). In general, DNA vaccines 
would seem to have been less successful than conventional or sub-unit 
protein vaccines in protecting against infection, probably due to a weak 
and short-lived immune response (Rothel et al., 1997; Schrijver et al., 
1997).  
In an effort to improve the efficacy of DNA vaccination against 
intracellular pathogens, fusion of antigen-encoding genes to those 
encoding specific “effector” molecules has been attempted. One such 
effector molecule is the cytotoxic T lymphocyte antigen-4 (CTLA-4) 
(Brunet et al., 1987), which assists in directing secreted vaccine antigens 
to lymph nodes and antigen-presenting cells (APCs) (Boyle et al., 1998; 
Drew et al., 2001). CTLA-4, a repressor of T-lymphocyte proliferation, is 
expressed on the surface of activated T cells. In its dimeric form it 
competes with CD28 for binding to the CD80 and CD86 (B7 domains) on 
antigen-presenting cells (Linsley et al., 1991; Thompson and Allison, 
1997). A truncated derivative of CTLA-4 (designated CTLA-4-HIg) was 
created, composed of the C-terminal end of the extracellular domain 
fused to the hinge CH2 and CH3 domains of human IgG1 (HIg); this 
derivative was able to dimerize as a result of the IgG hinge domains. 
Subsequently, chimeric proteins, consisting of antigen-encoding 
sequences fused to CTLA-4-HIg, were found to be specifically targeted 
to APCs (Boyle et al., 1998). In a later study it was shown, in vaccinated 
mice, that the antibody response to a T. ovis 45W antigen-CTLA-4-HIg 
fusion construct was 30 times higher than that achieved with non-targeted 
DNA vaccination. Furthermore, the kinetics of the antibody response to 
the targeted construct were faster than achieved with non-targeted DNA 
or with an adjuvanted protein vaccine; unfortunately, vaccination of 
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outbred sheep with the fusion vaccine failed to enhance immune 
responses (Drew et al., 2001).  
In the only report of the development of a DNA vaccine against C. 
pseudotuberculosis infection, De Rose et al. (2002) fused the sequence 
encoding the extracellular domain of bovine CTLA-4 (Parsons et al., 
1996) with that encoding the CH2 and CH3 domains of human IgG1 
(Boyle et al., 1998) and that of a genetically inactivated derivative of 
PLD (∆PLD) (Tachedjian et al., 1995), to generate the construct 
boCTLA-4-Ig-∆PLD. In an attempt to determine the optimal route of 
immunization, the DNA vaccine was administered either intramuscularly 
in the left thigh, subcutaneously in the groin, or via gene gun delivery 
into the skin of the lower rear flank. Subsequently, antibody responses 
and resistance to experimental challenge with C. pseudotuberculosis were 
examined. Before challenge, only intramuscular vaccination resulted in a 
significant (albeit minimal) increase in serum anti-∆PLD IgG 
concentrations. After challenge, antibody concentrations in animals 
vaccinated by the gene gun or subcutaneous method were not 
significantly higher than in non-vaccinated animals; however, IgG 
concentrations in intramuscularly vaccinated animals increased 
dramatically after challenge, suggesting a strong anamnestic response. 
Furthermore, sterile immunity (i.e., absolute protection from infection) 
was observed in 45% of animals vaccinated intramuscularly, which was 
similar to the results of a previous study (Hodgson et al., 1999) of 
vaccination with ∆PLD protein. IgG2 titres in animals vaccinated 
intramuscularly were significantly elevated, suggesting that a Th1 
immune response was responsible for the observed protection against 
infection.  
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1.5.5. Identification of immunodominant antigens: 
 In attempts to develop more refined CLA vaccines, PLD has been 
the main focus of research. This was due, in part, to the perceived 
importance of the toxin in the dissemination of C. pseudotuberculosis 
within the infected host (Carne and Onon, 1978) and to the observation 
that anti-PLD antibodies assist in clearance of C. pseudotuberculosis 
from experimentally infected animals (Eggleton et al., 1991). It is also 
probable that, in the absence of a C. pseudotuberculosis genome sequence 
and of information on other virulence determinants, PLD was favoured 
for inclusion in novel vaccines. However, as discussed above, C. 
pseudotuberculosis cell-associated antigens also contribute to protection 
against CLA (Brogden et al., 1990; Hodgson et al., 1992), and have even 
been suggested to be essential for the induction of optimal immunity 
(Cameron et al., 1969; Cameron, 1972; Burrell, 1983).  
In an investigation of immunodominant C. pseudotuberculosis 
antigens (Muckle et al., 1992), the presence of seven immunodominant 
proteins in whole-cell lysates of C. pseudotuberculosis was investigated 
with immune sera from goats with CLA. Of these seven proteins, three 
were consistently detected by all sera. Sodium chloride extracts of C. 
pseudotuberculosis contained all three immunodominant antigens, 
suggesting that they were loosely associated with the bacterial cell wall. 
Subsequent purification and functional analysis of the most strongly 
immunoreactive protein identified it as PLD; however, the identity of the 
two remaining antigens remained undetermined.  
In a later study, Walker et al. (1994) adopted a novel approach to 
the identification of immunodominant C. pseudotuberculosis antigens 
based on B lymphocytes derived from infected loci in sheep. Such 
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antibody-secreting cells (ASCs) had previously been shown to produce 
antibodies of highly restricted specificity (Meeusen and Brandon, 2006). 
After experimental infection of sheep with C. pseudotuberculosis in the 
right hock, bacteria drained to popliteal lymph nodes, from which site 
ASCs were subsequently obtained. The popliteal lymph nodes were 
dissected and mononuclear leucocytes were isolated. These leucocytes 
were cultured in the presence of mitogens, and the culture supernates 
were referred to as ASC probes. Immunoblots of C. pseudotuberculosis 
whole-cell lysates were performed with the ASC probes. A previously 
undescribed ca 40 kDa antigen was consistently and strongly recognized 
by the probes derived from all experimentally infected animals. The 
40 kDa antigen, which was present in C. pseudotuberculosis culture 
supernate, was subsequently purified by chromatography. Immunization 
of sheep with 100 µg of the purified antigen (later found to be a serine 
protease designated CP40 [Wilson et al., 1995]), resulted in ca 79% 
protection against experimental C. pseudotuberculosis infection. 
Vaccination with 5 µg of the antigen, although not inducing complete 
protection, significantly reduced the number of lung lesions in infected 
sheep.  
The results obtained through use of ASC probes were significant, 
since they revealed that the CP40 antigen, which was found in all C. 
pseudotuberculosis strains examined, was one of the earliest products to 
be recognized by the host during infection (Walker et al., 1994). There 
was no obvious relation between CP40 antibody titres and the amount of 
antigen administered or incidence of lung lesions, implying that cell-
mediated immunity was the main protective mechanism. 
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Chapter two 
Materials and Methods 
 
2.1. Sterilization: 
2.1.1. Hot-air oven: 
 Glassware like Petri dishes, pipettes, tubes, flasks and glass rods 
were sterilized in the hot air oven at 160oC for 1 hour. 
2.1.2. Autoclaving : 
 Sterilization of media, solutions, screw capped bottles; rubber-
stopper, etc were sterilized by autoclaving at 121oC(151b/square inch) for 
15 minutes and 110oC (10 Ib/square inch) for 5 minutes for sugar media. 
2.2. Collection of blood and serum: 
 Blood and serum used for the enrichment of media were collected 
by veni-puncture of the jugular vein of a healthy donor sheep. Blood 
obtained in sterile flasks with glass beads was defibrinated by shaking, 
and used for preparation of blood agar, and that needed for serum 
preparation was allowed to clot at room temperature for one hour, clot 
was separated from the walls of the container by using sterile glass rod, 
which were then transferred to refrigerator at 4oC and left overnight. 
Serum which collected was pipette into centrifuge tubes and centrifuged 
at 3000, r.p.m. for 10 minutes and clear straw-cloured fluid was dispense 
in 10ml amounts, inactivated in water-bath at 56oC for 10 minutes then 
stored frozen at -20oC until needed. This serum was used for serum agar. 
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2.3. Preparation of media: 
2.3.1. Solid media: 
2.3.1.1. Nutrient Agar: 
 Twenty-eight grams of dehydrated nutrient agar (Oxoid CM3) 
were suspended in 1 liter of distilled water, steamed to dissolve 
completely; the pH was adjusted to 7.4 and then sterilized by autoclaving 
at 121oC for 15 minutes. 
2.3.1.2. Blood Agar Medium: 
 Forty grams of blood agar base (Oxoid CM55) were suspended in a 
liter of distilled water, steamed to dissolve, cooled and the pH adjusted to 
7.4. It was then sterilized by autoclaving at 121oC for 15 minutes. After 
cooling to about 46oC, defibrinated sheep blood was added aseptically in 
7-10% concentration. 
 The medium was then distributed in 20ml amounts in sterile Petri-
dish. 
2.3.1.3. Dorset egg medium: 
 The medium was prepared according to the method described by 
Cheesbrough (1984). The procedure was as follows: Two hen-eggs were 
cleaned and swabbed with 70% ethanol, dried, the shell cracked and the 
contents mixed thoroughly with 20ml of sterile nutrient broth to produce 
homogeneous mixture which was distributed in 2.5ml slow heating at 
75oC in slope position and maintained at this temperature for one hour. 
The procedure was repeated for two consecutive days. 
2.3.1.4. Serum agar medium: 
The medium was prepared according to Cowan (1985) by addition 
of 10% sterile serum to melted nutrient agar. 
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2.3.1.5. Christensen's medium: 
 The medium was used for the detection of urea splitting organisms. 
It was prepared by dissolving 2.4 g of urea agar base (Oxoid) in 95ml 
distilled water, sterilized and cooled to 45oC before 5 ml of sterile 40% 
urea solution (Oxoid SR20) were added aseptically. The mixture was 
distributed in 10ml amounts into McCartney bottles and allowed to 
solidify as slopes. 
2.3.1.6. Motility medium: 
 The medium was composed of tryptose, sodium chloride and agar. 
It was prepared according to manufacturer's instructions by dissolving 
20g of the dehydrated powder in 1 liter distilled water, distributed in 5ml 
amounts into 10ml test tubes covered with cotton wool and sterilized. 
2.3.2. Semi solid media: 
2.3.2.1. Hugh and leifson's (O.F. medium): 
 The oxidation fermentation medium was used to test the ability of 
the organism to break down the carbohydrates by oxidation and/or 
fermentation. The medium contained peptone, sodium chloride, 
dipotassium hydrogen phosphate, agar and 0.2% aqueous solution of 
bromocresol purple. It was prepared according to Cowan (1985) by 
dissolving the solids in distilled water. The pH adjusted to 7.1, the 
medium was filtered and the indicator was added. Sterile solution of 
appropriate carbohydrate was then added aseptically to give a final 
concentration of 1%, the content was distributed aseptically in 10ml 
amounts into sterile test tubes and covered with cotton wool. 
2.3.3. Liquid media: 
2.3.3.1. Nutrient broth: 
 Thirteen grams of dehydrated (Oxoid ,CM1) nutrient broth were 
suspended in a liter of distilled water, mixed well and the pH was 
adjusted to 7.4 and then sterilized by autoclaving at 121oC for 15 minutes. 
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This medium was used as base for carbohydrate utilization test and for 
other purposes. 
2.3.3.2. Brain heart infusion broth: 
 This medium contained calf brain and beef heart infusion solids, 
peptone, dextrose, sodium chloride and di-sodium phosphate. It was 
prepared according to manufacturer's instructions by dissolving 37g of 
the powder in 1 liter distilled water and sterilized . 0.1 % of tween 80 was 
added to media before sterilized to enhance the growth. 
2.3.3.4. Nitrate broth: 
 The medium was prepared according to Cowan (1985) by 
dissolving 1g of potassium nitrate in 1 liter of nutrient broth, distributed 
into bijou bottles in 3 ml amounts and sterilized. 
2.3.3.5. Carbohydrate fermentation media: 
 An amount of 900ml peptone water was prepared and its pH was 
adjusted to 7.1, 10 ml of 0.2% aqueous solution of bromocresol purple 
were added and the medium then was sterilized. The sugar was prepared 
by dissolving 10 g in 90ml distilled water and sterilized. Sugar was added 
aseptically to sterile peptone water and the indicator. It was then 
distributed in 3 ml amounts into sterile bijou bottles with inverted 
Durham's tubes. All the bottles were labeled before use. 
2.3.4. Reagents: 
2.3.4.1. Tetramethyl-p-phenylene diamine dihydrochloride: 
 It was prepared fresh as 1% aqueous solution and used for oxidase 
test. 
2.3.4.2. Hydrogen peroxide (H2O2): 
 It was prepared as 3% aqueous solution and used for catalase test. 
2.3.4.3. Potassium hydroxide (KOH): 
 It was prepared as 40% solution and used in VP test. 
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2.3.4.4. Nitrate test reagent: 
         Nitrate reagent was composed of two solutions: 
Solution (A): 0.8% sulphanilic acid in 5N-acetic acid. It was prepared by 
mixing 0.4ml of sulphanilic acid in 50ml of 5N-acetic acid. Solution (B): 
0.5% dimethyl-α-naphthylamine in 5N acetic acid. 
2.3.4.5.α-Naphthol solution: 
 It was prepare as 5% and used for VP test  
2.3.5. Indicators: 
2.3.5.1. Bromocresol purple: 
 It was prepared as 0.2% aqueous solution and used as indicator for 
different purpose. 
2.3.5.2. Zinc powder: 
 It was used for nitrate reduction test in 5 mg/ml culture.  
2.3.6. Solution: 
2.3.6.1. Normal saline: 
 It was prepared by dissolving 8.5g sodium chloride in 1 liter 
distilled water. 
2.4. Collection of samples: 
 Samples were collected from carcasses during meat inspection in 
Al Huda slaughterhouse at Omdurman Province. A total number of 
157grossly enlarged lymph nodes were collected, labeled, stored in ice 
box and transported to the Central Veterinary Research Laboratory. 
2.5. Isolation of Corynebacterium pseudotuberculosis: 
2.5.1. Primary isolation: 
 The fat and fascia covering the affected lymph  nodes were 
removed using sterile scissors. A hot scalpel blade was singe the surface 
of the lymph nodes prior to incision aseptically, and swabs were taken 
from the periphery of the lesion and streaked into 7% sheep blood agar 
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plates. These were then incubated in a desicator, under 10% Co2 tension 
at 37oC for 48 hours. 
2.5.2. Purification 
 Typical and well isolated colony was purified by transferring to a 
blood agar plates and incubated aerobically at 37oC for 48 hour. This 
process was repeated till purification was obtained. 
2.5.3. Identification of purified bacteria: 
2.5.3.1. Cultural characteristic: 
 The growth characteristic of the colonies on blood agar plates 
including the colonial shape, size, colour and haemolysis were checked. 
2.5.4. Primary test: 
2.5.4.1. Gram's stain: 
 Smears were prepared by emulsifying a small inoculum in a drop 
of normal saline and spread it on a clean slide. The smears were allowed 
to dry in air and then fixed by gentle flaming. The prepared slides were 
placed on the rack and flooded with crystal violet stain for one minute. 
The slide was left covered with iodine for one minute, rinsed with water, 
acetone was poured for no time, and the slides were rinsed with water 
again. The slides were counter stained with carbol fuchsin for one minute. 
Rinsed in water and allowed it to dry by blotting it with filter paper. 
2.5.4.2. Motility: 
 The test strain was inoculated into motility medium using straight 
wire and incubated at 37oC for 48 hours. Motile bacteria spread away 
from the inoculated line. 
2.5.4.3. Aerobic and anaerobic growth: 
 Cultured media were incubated aerobically and anaerobically using 
Gas PAkJar. 
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2.5.4.4. Oxidase test: 
 The organism was taken by sterile glass rod and smeared in a 
surface of filter paper saturated by fresh 1% tetramethyl-p-phenylene 
diamine dihydrochloride. Positive reaction indicated by formation of 
purple color within 10 seconds. 
2.5.4.5. Catalase test: 
 The organisms were streaked on serum agar, incubated at 37oC for 
48hours. A small amount of culture was picked with sterile Pasteur 
pipette, placed on clean slide, and then a drop of 3% aqueous solution of 
hydrogen peroxide was placed over the culture and observed for 
production of gas bubbles during 10 seconds. 
2.5.4.6. Oxidation fermentation of carbohydrate:  
 Two tubes containing Hugh and Leifson's medium were inoculated 
with the test organism by stabbing with straight wire. The medium in one 
of the inoculated tubes was covered with a layer of sterile liquid paraffin 
oil to depth of 1 cm. The tubes were incubated and examined daily for 14 
days, change of colour to yellow in both tubes indicated that the organism 
is fermentative, but the yellow colour in the open tube only indicated that 
the organism is oxidative. 
2.5.5. Biochemical test: 
2.5.5.1. Sugar fermentation: 
 Each test organism was cultured in Bijou bottles containing various 
peptone water sugars, incubated at 37oC and examined for acid and gas 
production during 14 days. Positive reaction was indicated by changes of 
colour to yellow due to acid production, and Durham's tubes examined 
the gas production. This test was carried out on media containing glucose, 
maltose, and lactose. 
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2.5.5.2. Nitrate reduction: 
 Inoculated nitrate broth was incubated for up to five days. Then 
one ml of nitrate reagent solution (A) was added followed by 1 ml of 
nitrate reagent solution (B). 
 Positive reaction was indicated by the development of red colour. 
To tube not showing red colour within five minutes, powdered zinc was 
added, the development of red colour indicated that nitrate was not 
reduced. 
2.5.5.3. Urease test:  
  A urea agar slant was streaked with the test organism and 
incubated at 37oC for 24-48 hours. The development of a pink colour was 
indicative of production of NH3. Negative and weak tests were left for a 
week before taking results. 
2.5.5.4. Voges-Proskauer test: 
 Glucose phosphate broth was cultured with the test culture and 
incubated for 48 hours. To five  ml of culture, 0.6ml of 5% α-naphthol 
was added followed by 0.2ml of 40% KOH. The tube was thoroughly 
mixed and sloped  for up to 60 minutes. Positive reaction was indicated 
by a strong red colour. 
2.5.6. Storage and labeling of bacterial isolates:                   
        The isolates which were considered to be Corynebcacterium were 
carefully labeled and preserved on blood agar slant ,Dorset egg medium 
and lyophilized (stored in -20c) 
2.5.6. Inhibition of staphylococcal beta toxin: 
 This test was done according to the method described by Lovell 
and Zaki (1966).In this test  Corynebcacterium pseudotuberculosis 
exotoxin occupied the receptor site on the erythrocytes membrane 
preventing the beta lysin from exerting its haemolytic effect. This method 
had sensitivity and specificity level of 92%-96% respectively. 
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 Four colonies of Corynebacterium pseudotuberculosis were 
cultured in a four corners of proposition square had equal diameter on 
bovine blood agar plate and in the middle of the square one colony of 
Staphylococcus aureus was cultured.  
2.6. Determination of short chain fatty acids composition by Gas 
liquid chromatography: 
2.6.1. Sample preparation for GLC analysis: 
 Direct transmethylation of fatty acids from examined bacterial 
samples without prior exteraction was done as described by (Dionisi et 
al.1999). 
 One ml of Metlhanolic HCl (1.5 M) was added to 100mg of dried 
bacterial samples, vortexed for 5-10 sec and 1 ml of methanol was also 
added. The sample was incubated in a water bath at 80oC for 10 min. Two 
ml of distill water were added and finally centrifuged at 2500rpm for 5 
min. The upper two third of the supernatant was used for gas liquid 
chromatography analysis. 
 
2.6.2. Preparation of standard: 
 The standards acetic acid, propionic acid, butyric acid, valeric acid, 
isovalaric acid, caporic acid and isocaporic acid were prepared as 
described by Holdman and Moore (1975). 
A 0.4 ml of 50% H2SO4 and 0.8g NaCl were added to 2 ml of standard. 
Two ml of diethyl ether was added, the tube was stoppered and shaked 
about 20 times. Centrifugation at 2500 rpm for 5 min was done to break 
the emulsion and the ether layer was pipetted off. 
2.6.3. Gas liquid chromatography: 
 Samples were analyzed in gas chromatograph (Shimadzu GC 
Model 2010). Routine condition of analysis were: detector (Flame 
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ionization detector) 110oC, injector pore 110oC, column (DBI 30 meter) 
95oC. The carrier gas was nitrogen. The sample size was 2µl. 
2.7. Identification of Corynebacterium pseudotuberculosis isolated 
from sheep by PCR: 
2.7.1. DNA extraction: 
 A 10 ml of fresh brain heart infusion broth culture was centrifuged 
at 4C (2000g for 20mi) and chromosomal DNA extraction was performed 
by Quiageen kits. 
2.7.2. Primer and PCR condition: 
 The primer used in this study is targeting the 16rRNA gene of 
Corynebacterium pseudotuberculosis was obtained from previously 
published work (Cetinkaya et al. 2002). 
 The length of the primers were 20bp and the annealing temperature 
was 55oC. The forward primer had the sequence 
ACCGCACTTTAGTGTGTGTG (E. coli position 183-203) and the 
reversed primer was TCTC TACGCCGATCTTGTAT (E. coli position 
1019-999). 
The PCR was performed in a thermocycler (PeQlab biotechnologie 
GmbH, Germany) in a final reaction volume of 25µl containing 2.5 µl of 
PCR Buffer, MgCl 50UM (1 µl), 1 µl of each deoxynucleotide 
triphosphate, 0.4µl of Tag DNA polymerase, 1µl of each primer, 2.5µl of 
template DNA and 15.6µl D.W. Amplification was obtained with 30 
cycles following initial denaturating step at 94oC for 5 min. Each cycle 
involved denaturation at 94oC for 1 min., annealing at 56oC for 1 min., 
and synthesis at 72oC for 2 min. 
2.7.3. Electrophoresis: 
 The amplified products were detected by ethidium bromide 
staining after electrophoresis for 1 hour in 1.5% agarose gel.  
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2.8. Pathogenicity in mice: 
 This experiment was done by using five strains according to the 
differences in the biochemical activities and fatty acids contents. One 
colony of each strain from blood agar plates was inoculated in 5ml of 
sterile brain heart infusion broth plus (o.1%) Tween 80 and incubated for 
48 hours at 37oC. A dose of 0.2 ml of fresh culture was injected s/c to a 
group of five mice each. Control group was  injected s/c by 0.2 ml of 
sterile normal saline. 
 Mice were observed for 10 days post inoculation for deaths and 
abscess development. Dead as well as surviving animals were autopsied 
and their internal organs (lung, heart, liver, spleen, kidney) were 
inspected, smeared and Gram stained, and cultured on blood agar plates. 
A small part of these organs were fixed in 10% formalin and processed 
for histopathology.   
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                                          Chapter three 
Results 
 
3.1. Post mortem findings: 
 A total numbers of 3875 sheep carcasses were examined and a total 
of 157 lymph node abscesses were collected for bacteriological 
examinations. 
 From 129 infected sheep carcasses 104 had a single lymph node 
abscess and in 25 sheep carcasses the infected lymph nodes were found in 
two or more different sites at the same carcasses. 
Table (1) showing the general features of abscessation in investigated 
sheep. 
Table (2) showing the distribution of lesions in inspected sheep carcasses.  
 From 157 lesions colleted in this study, Corynebacterium 
pseudotuberculosis isolated from 49 samples.  
3.2. Microbiological and biochemical examinations: 
3.2.1. Morphology and staining: 
 In Gram-stained smears the test organism appeared as Gram-
positive, the cell range from coccoid to filamentous, exhibiting a 
tendency to form clumps palisade arrangement simulating Chinese letters. 
The organism was non motile, non sporforming and uncapsulated. 
3.2.2. Growth characteristics 
3.2.2.1. Blood agar medium: 
 The organism was cultured in blood agar medium and incubated at 
37oC for 48 hours. Colonies were off-white, dull, faintly haemolytic and 
about 1mm in diameter. The colonies could be pushed across the agar 
medium without disintegrating (some describe this as pushing a "hockey 
puck"). 
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3.2.2.2. Serum agar: 
 Colonies were small, translucent and as colonies aged they became 
opaque, dry and crumbly with cream to orange colour. 
 
3.2.2.3. Dorset egg medium  
 On the surface of the slope the organism was forming a thin 
yellowish film after 48 hours of incubation at 37oC. 
3.2.2.4. Brain heart infusion broth: 
 In this medium the growth obtained after 48hours forming granular 
deposit with a surface pellicle with no general turbidity. 
3.2.3. Biochemical properties: 
 All isolates of Corynebacterium pseudotuberculosis were negative 
for oxidase, lactose, V.P. and did not reduce nitrate. But all isolates were 
positive to catalase, urease and starch. All isolates produced acid but not 
gas from fermentable sugars. Table (3) showing the biochemical 
characteristics of C. pseudotuberculosis isolated from sheep carcasses. 
3.3. Inhibition of staphylococcal beta toxin: 
 All strains tested were inhibited staphylococcal beta toxin 
(phospholipase c) activity on bovine blood agar by C. pseudotuberculosis 
(phosphoipase D). 
3.4. Gas liquid chromatography: 
          In all strains tested by GLC Propionic acid was found and  formed 
the highest peak but Valaric  acid was not detected. 
 The percentage composition of the short chain fatty acid from 20 
strains examined shown in fig 3,4,5,6 and table (3). 
3.5. Identification of Corynebacterium pseudotuberculosis by PCR: 
PCR products with the molecular size of 815 bp were considered as 
Corynebacterium pseudotuberculosis. The five strains were positive by 
PCR. 
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3.6. Pathogenicity results: 
 The five strains different in their pathogenicity to mice. Strains 2 
and 13 were the most pathogenic ,caused acute disease and death during 
2-5 days. The organism was demonstrated in Gram-stained smears and   
re- isolated from the liver, spleen, kidney and lung. 
 Strains 11and 65 was less pathogenic, caused death during 4-7 
days, the mortility rate was 80% and 60% respectively and the organism 
were isolated from the internal organs on blood agar plates. 
 Strain 64 was not pathogenic but the organism was isolated from 
internal organs. 
3.6.1. Post mortem findings: 
 The internal organs was congested and the spleen was enlarged and 
congested. 
3.6.2. Histopathological findings :     
Histopathological changes in all groups was same but the 
differences was in the severity of changes. 
 In the liver there was haemorrhage, congestion, focal inflammatory 
cells and hepatic cells showed necrosis with pyknotic nuclei and 
cytoplasmic vacules.  The kidney showed congestion, haemorrhage, and 
renal tubules necrosis.  
In the lung there was congestion and haemorrhage, thickening of 
alveolar septa and inflammatory cells were also observed. In the heart 
there was cardiac muscle degeneration. 
The spleen showed depletion of lymphocytes, giant cells and RBCs . 
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Table 1: The distribution of abscesses in inspected sheep          
carcasses. 
 
Total number of sheep examined 
 
3875 
 
Infected sheep 
 
(129) 3.32% 
 
Carcasses with single lesion 
 
(104) 80.62% 
 
Carcasses with two lesions 
 
(23) 17.83% 
 
Carcasses with three lesions 
 
(2) 1.5% 
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Table 2: Distribution of lesions in examined sheep carcasses 
 
 
 
 
 
 
 
 
 
 
 
Total lesions 
 
157 
 
Mandibular 
 
9 (5.78) 
 
Parotid 
 
41(26.11) 
 
Prescpular 
 
30 (19.10) 
 
Precrural 
 
22 (14.01) 
 
Popliteal 
 
15 (9.55) 
 
Inguinal 
 
8 (5.09) 
 
Pulmonary 
 
12 (7.64) 
 
Hepatic 
 
14 (8.91) 
 
Mediastinal 
 
6 (3.81) 
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Table 3: Biochemical characteristics of Corynebacterium 
pseudotuberculosis isolated from abscesses.  
 
 
Test 
 
Reaction (%) 
 
Oxidase 
 
-ve ( 0%) 
 
Catalase 
 
+ve (100%) 
 
O.F. 
 
+ve (100%) 
 
Glucose 
 
+ve (100%) 
 
Lactose 
 
-ve ( 0%) 
 
Maltose 
 
+ve (93.8%) 
 
Urease 
 
+ve (100%) 
 
V.P. 
 
-ve ( 0%) 
 
Nitrate 
 
-ve (0%) 
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Fig. (1): Gram stained Corynebacterium pseudotuberculosis. 
 
 
Fig. (2): Inhibition of Staphylococcal beta toxin activity on bovine 
blood agar by Corynebacterium pseudotuberculosis (phospholipase 
D). 
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Fig. (3): % composition of short chain fatty acid of Corynebacterium 
pseudotuberculosis isolates. 
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Fig. (4): % composition of short chain fatty acid of Corynebacterium 
pseudotuberculosis isolates. 
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Fig. (5): % composition of short chain fatty acid of Corynebacterium 
pseudotuberculosis isolates. 
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Fig. (6): % composition of short chain fatty acid of Corynebacterium 
pseudotuberculosis isolates. 
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Fig 7: Identification of Corynebacterium pseudotuberculosis    
isolates by PCR. 
 
 
 
 
 
 
 
 
 
16 srRNA  
815 bp 
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Fig. (8): Stain H&E (X10).Congestion, haemorrhage and granuloma in 
kidney.  
 
 
Fig.(9): Stain H&E (X40).Focal inflammatory cells and congestion in 
liver. 
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Fig. (10): Stain H&E (X40).Congestion, thickening in  alveolar septa and 
inflammatory cells in lung. 
 
 
Fig.(11):Stain H&E (X40).Haemorrhage and cardiac muscle degeneration 
in heart. 
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Fig. (12): Stain H&E (X40).Depletion of lymphocytes, Giant cells and 
RBCs in spleen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 60
Chapter Four 
Discussion 
 
 Caseous lymphadenitis of sheep has been a significant disease in 
the majority of sheep-rearing regions for over a century, because of the 
chronic and often subclinical nature of the infection. 
 In Sudan the disease is associated with economic losses in a variety 
of ways, which include meat condemnation and down grading of hide. 
Labour cost and antibiotics used in combating the disease were additional 
factors of economical loss. 
 The purpose of this study was isolation of corynecbacterium 
pseudotuberculosis, compare the percentage composition of short chain 
fatty acids from isolated strains, identification of isolates by PCR and 
study their pathogenicity in mice. 
 In Khartoum state, Khalid (1971) studies the causative organisms 
isolated from caseated lymph nodes of sheep while Hamad et al. (1992) 
dealt with the aetiology of abscesses of sheep and Ahmed (1994) 
investigated the sources of infection . Elgaddal (1997) studied the 
prevalence, aetiology and diagnosis of CLA by serological tests in South 
Darfur State.  
 In this study the lesions of sheep abscesses were found in order of 
frequency of infection in the parotid, prescapular, precrural ad popliteal 
lymph nodes. The parotid lymph nodes were found to be the most 
affected ones. Our findings are in agreement with (Asfag and Campell, 
1979) and Elgaddal (1997) who suggested that ear marking which takes 
the form of certain cuts for identification might be a possible route of 
infection. 
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 Carne (1939), Maddy (1953) and Batey (1986) suggested that 
infection by C. pseudotuberculosis occurred through wounds or mucus 
membranes followed by spread to the regional lymph nodes. This 
suggestions supported the findings reported in this study.  
 From 157 pus samples, 6 samples were bacteriological negative. 
These findings were in agreement with these of Aynaud (1923) and Carre 
(1923b) who reported that only one pus sample out of 37 and 20 
respectively were bacteriologically negative.  Also Elgaddal reported that 
15 out of 351 (4.27%) of pus samples were bacteriologically negative. 
This could be attributed to the destruction of bacteria by host defense 
mechanisms. 
 Kuria and Ngatia (1990) stated that the pus was green-yellow to 
creamy greenish-yellow, where a Ayers (1977), Stoops (1984) and Lioy 
et al (1990) described the pus as thick and greenish white in colour. 
However, the degree of green colouration was due to the presence of the 
enzyme myeloperoxidase (Tizard, 1992). 
 From our observations during this study the lesions of CLA 
containing cheesy pus. This was in agreement with the finding of Hamacd 
et al (1992) and Elgaddal (1997).  
         Identification of  C. pseudotuberculosis by specific-PCR might  be 
useful for several reasons. First, the antigenic similarities between 
Corynebacterium species is the major cause of a significant number of 
false-negative and false-positive results in serological test. This has 
hindered the use of serological test to monitor C.L.. Second, 
bacteriological test have some drawbacks as well. The most important 
drawbacks is to variation in biochemical characteristics of 
Corynebacterium species which has hampered the use of routine 
bacteriology in differentiating the species belonging to the genus 
(Hommez et al ., 1999). 
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In this study C.pseudotuberculosis specific PCR was used to 
identify 5 strains which had difference percentage composition of short 
chain fatty acid and used in pathogenicity  experiment . 
         In this study we used gas liquid chromatography for qualitatively 
and quantitatively assess of short chain fatty acid among 20 isolates. 
 Propionic acid formed the highest peak, butric, isovalaric, caporic 
and isocaporic acid are also present but none of them as major peak. 
These finding agreed with Reddy (1978) who find that C. 
psudotuberculosis produced a major amount of propionic acid and formic 
acid as a metabolic products. 
 The highly pathogenic strains have a high content of propionic acid 
while the non pathogenic strain has low concentration of propionic acid. 
 In view of that, we put forward, the fact that the content of 
propionic acid might has a direct influence on the pathogenicity of C. 
pseudotuberculosis. 
 From the results of pathogenicity experiment it was shown that C. 
pseudotuberculosis, isolated from a natural case of caseous lymphadenitis 
could cause acute disease in white mice. Other aspect that must be 
considered is the period of observation was not long enough for abscesses 
formation in the internal organs and site of inoculation. 
 The important finding was the intense infiltration of 
polymorphoneuclear inflammatory cells and that indicating acute 
infectious process. Similar findings were observed by Junior and Oliveria 
(2006) in their study of experimental infection of goats by 
Corynebacterium pseudotuberculosis. 
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Conclusions and Recommendations 
 
 
 
Conclusions: 
From the results obtained we can conclude the following: 
• There were qualitative and quantitative differences in short chain 
fatty acids among the isolates and this is a considerable taxonomic value 
to differentiate between strains. 
 
• The local Sudanese isolates of C. Pseudotuberculosis are 
genetically    identical. 
.  
Recommendations: 
•  Accordingly, more work is warranted to study more other factors 
and mechanisms of virulence. 
 
•  From my opinion, accurate serodiagnosis together with 
vaccination must be the main strategy to control CLA in Sudan.         
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